CoPRA: Bridging Cross-domain Pretrained Sequence Models with Complex Structures for Protein-RNA Binding Affinity Prediction
Rong Han, Xiaohong Liu, Tong Pan, Jing Xu, Xiaoyu Wang, Wuyang Lan, Zhenyu Li, Zixuan Wang, Jiangning Song, Guangyu Wang, Ting Chen
TL;DR
CoPRA tackles the challenge of predicting protein-RNA binding affinity by bridging cross-domain pretrained language models for proteins and RNAs with explicit complex-structure information. A Co-Former fuses interface sequence embeddings and a structure-derived pair representation, guided by bi-scope pre-training with CPRI and MIDM on the PRI30k dataset. The approach yields state-of-the-art performance on PRA310 and PRA201 for ΔG prediction and robust mutation-effect predictions, demonstrating strong generalization and scalability. This cross-domain, structure-aware framework provides a blueprint for extending high-precision affinity predictions to broader biomolecular interactions and mutation analyses, particularly as dataset sizes grow and model scales increase.
Abstract
Accurately measuring protein-RNA binding affinity is crucial in many biological processes and drug design. Previous computational methods for protein-RNA binding affinity prediction rely on either sequence or structure features, unable to capture the binding mechanisms comprehensively. The recent emerging pre-trained language models trained on massive unsupervised sequences of protein and RNA have shown strong representation ability for various in-domain downstream tasks, including binding site prediction. However, applying different-domain language models collaboratively for complex-level tasks remains unexplored. In this paper, we propose CoPRA to bridge pre-trained language models from different biological domains via Complex structure for Protein-RNA binding Affinity prediction. We demonstrate for the first time that cross-biological modal language models can collaborate to improve binding affinity prediction. We propose a Co-Former to combine the cross-modal sequence and structure information and a bi-scope pre-training strategy for improving Co-Former's interaction understanding. Meanwhile, we build the largest protein-RNA binding affinity dataset PRA310 for performance evaluation. We also test our model on a public dataset for mutation effect prediction. CoPRA reaches state-of-the-art performance on all the datasets. We provide extensive analyses and verify that CoPRA can (1) accurately predict the protein-RNA binding affinity; (2) understand the binding affinity change caused by mutations; and (3) benefit from scaling data and model size.
